Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-9,199
Closed -$1.01M 225
2015
Q3
$1.01M Buy
+9,199
New +$1.03M 0.02% 192
2015
Q2
Sell
-9,218
Closed -$845K 403
2015
Q1
$845K Sell
9,218
-2,425
-21% -$200K 0.01% 239
2014
Q4
$851 Sell
11,643
-11,130
-49% -$727K 0.01% 235
2014
Q3
$1.12K Sell
22,773
-534
-2% -$26.8K 0.01% 244
2014
Q2
$1.31M Buy
23,307
+5,331
+30% +$272K 0.06% 236
2014
Q1
$962K Sell
17,976
-8,563
-32% -$531K 0.04% 256
2013
Q4
$1.34M Sell
26,539
-17,428
-40% -$758K 0.03% 352
2013
Q3
$1.68M Buy
43,967
+2,269
+5% +$67K 0.05% 292
2013
Q2
$917K Buy
+41,698
New +$911K 0.01% 479

Other funds holding INCY

NatWest Group's INCY Position: Q4 2015 in Review

NatWest Group sold out of Incyte (INCY) in Q4 2015, closing a stake of 9,199 shares — an estimated $1.01M sold.

NatWest Group first reported a position in INCY in Q2 2013 and held it in 9 quarters. The position peaked at $1.68M in Q3 2013. 380 funds tracked by Wall St. Rank hold INCY as of Q4 2015.

  • NatWest Group reported no remaining Incyte position as of Q4 2015 after selling out during the quarter.
  • NatWest Group sold 9,199 Incyte shares in Q4 2015, an estimated $1.01M.
  • NatWest Group first reported a position in Incyte in Q2 2013 and held it in 9 quarters.
  • NatWest Group's Incyte position peaked at $1.68M in Q3 2013.
  • 380 funds tracked by Wall St. Rank held Incyte as of Q4 2015.

Based on NatWest Group's 13F filing for Q4 2015, filed 16 Feb 2016.